Purpose
To investigate levels of oxysterols in healthy control (HC) and multiple sclerosis (MS) patients and their inter-dependence with demographic, clinical characteristics and cholesterol biomarkers.
Methods
This study included 550 subjects (203 HC, 221 relapsing-remitting MS (RR-MS), 126 progressive MS (P-MS)). A complete lipid profile including total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), apolipoproteins (Apo) A1, A2, B, E, C-reactive protein (CRP), 24-hydroxycholesterol (24HC), 25HC, 27HC, 7αHC and 7-ketocholesterol (7KC) was obtained. Lipoprotein particle sizing by H1 NMR was available for 432 subjects.
Results
The levels of 24HC, 27HC, and 7αHC (all p < 0.015) were lower in MS compared to HC, and 7KC was higher in P-MS compared to RR-MS (p < 0.001). TC, LDL-C and ApoB were associated with higher levels of all oxysterols (all p < 0.05) in HC. In MS, LDL-C was associated with higher levels of 24HC, 25HC, 7KC, and 7αHC (all p < 0.05), while TC and ApoB were associated with increased levels of all oxysterols (all p < 0.005).
Conclusions
The findings of lower 24HC, 27HC and 7αHC in MS compared to HC and higher 7KC in P-MS compared to RR-MS indicate that the oxysterol network is disrupted in MS.